Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Stein

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Clinical Advances in Hematology & Oncology : H&O|June 12, 2026
Targeting human kallikrein 2 in prostate cancerMark N Stein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Striving Toward a Cure for Prostate CancerMark N Stein, Thomas L Jang
Oncology (Williston Park, N.Y.)|April 6, 2010
HDAC inhibitor research: still in its infancySerena T Wong, Mark N Stein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Reply to C.G. DrakeMark N Stein, Thomas L Jang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2018
The Immunobiology of Kidney CancerCharles G Drake, Mark N Stein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
CCR drug updates: sorafenib and sunitinib in renal cell carcinomaMark N Stein, Keith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2012
Abiraterone in prostate cancer: a new angle to an old problemMark N Stein, Susan Goodin, Robert S Dipaola
Translational Cancer Research|December 19, 2024
Adjuvant therapy in renal cell carcinoma (RCC): progress, at lastAndrew N Bueno, Mark N Stein, Karie Runcie
Frontiers in Oncology|March 6, 2018
Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate CancerJohnny R Ramroop, Mark N Stein, Justin M Drake
The Urologic Clinics of North America|April 15, 2026
Treatments on the Horizon for Men with Advanced Prostate CancerMatthew I Ehrlich, Ron S Gejman, Ezra Bernstein, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Clinical Advances in Hematology & Oncology : H&O|June 12, 2026
Targeting human kallikrein 2 in prostate cancerMark N Stein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Striving Toward a Cure for Prostate CancerMark N Stein, Thomas L Jang
Oncology (Williston Park, N.Y.)|April 6, 2010
HDAC inhibitor research: still in its infancySerena T Wong, Mark N Stein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Reply to C.G. DrakeMark N Stein, Thomas L Jang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2018
The Immunobiology of Kidney CancerCharles G Drake, Mark N Stein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
CCR drug updates: sorafenib and sunitinib in renal cell carcinomaMark N Stein, Keith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2012
Abiraterone in prostate cancer: a new angle to an old problemMark N Stein, Susan Goodin, Robert S Dipaola
Translational Cancer Research|December 19, 2024
Adjuvant therapy in renal cell carcinoma (RCC): progress, at lastAndrew N Bueno, Mark N Stein, Karie Runcie
Frontiers in Oncology|March 6, 2018
Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate CancerJohnny R Ramroop, Mark N Stein, Justin M Drake
The Urologic Clinics of North America|April 15, 2026
Treatments on the Horizon for Men with Advanced Prostate CancerMatthew I Ehrlich, Ron S Gejman, Ezra Bernstein, et al.
Pageof 10